Regarding CD4+ and CD8+ diversity, some author have reported a greater CD4+ diversity in the periphery (27, 28) and similar results have been described in lung adenocarcinoma (37), but to our knowledge, this has not been evaluated in BC. The gene discussed is CD4; the disease is lung adenocarcinoma.